graduate at Farmácia Bioquímica from Universidade Federal de Goiás (1997), master's at Infectious and Parasitic Illnesses from Universidade Federal de Goiás (2001) and ph.d. at Microbiology from Universidade Federal de São Paulo (2005). Has experience in Immunology, focusing on Applied Imunology, acting on the following subjects: chlamydia trachomatis, pcr, eia, dfi and ameloblastoma. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Venous thromboembolism (VTE) is a common complication in patients with active cancer. Cancer patients are at risk of developing a VTE 4 to 7 times higher than the general population, and it is associated with an annual recurrence rate of 21%, bleeding risk of 12%, leading to the need for anticoagulation for a long period and cessation of chemotherapy. Chemotherapy increases the risk of VT…
The main reason of cancer-related mortality is the spread of cancer cells to distant sites (micrometastases). However, only a few small groups of tumor cells can metastasize by acquiring mechanism to decrease the immune response. Changes in the systemic inflammatory response to the tumor can be measured by blood-based parameters. In particular, the proportion of neutrophiles- lymphocytes …
Head and neck cancer represents 6% of new cancer cases diagnosed annually, accounting for 650,000 new cases around the world. Its management is multidisciplinary and despite all efforts, about 50% of patients show disease recurrence.The spread of cancer requires the presence of circulating tumor cells (CTCs), which are rare cells surrounded by billions of hematopoietic cells.There are som…
Immunotherapy has provided beneficial results for cancer patients. Recently, the ANVISA, based on the KEYNOTE-355 study, approved the use of the immune checkpoint inhibitor (ICI) pembrolizumab plus chemotherapy for patients with unresectable locally recurrent or metastatic triple-negative breast cancer, with PD-L1 expression e 10. Although the results are encouraging, evidence suggests th…
Ovarian Cancer is one of the Cancers with higher mortality in women, especially among the periods of menopause/postmenopause. Its characterization is important for diagnosis/specific treatments. Regardless of therapeutic advances, most patients succumb to the disease. Mutations of the BRCA1 or BRCA2 genes can lead to resistance to platinum-based chemotherapy. A new type of therapeutic app…
Renal carcinoma represents one of the 10 most common cancers in the world and it is part of a heterogeneous group whose one of the main histological variants is the clear cell renal cell carcinoma (CRCC). Few methodologies are available for the early detection of this neoplasm. Due to the tumor heterogeneity, several studies have been carried out for the molecular characterization, throug…
Circulating Tumor Cells (CTCs) are rare cells that detach from some tumor site, invade blood vessels, being able to achieve new sites to form single or multiple micrometastasis. Desmoid tumor, also known as aggressive fibromatosis, is a rare, locally invasive, and non-metastasizing type of cancer. Soft tissue and bone sarcomas include a large group of several heterogeneous subtypes of mes…
(Only some records are available in English at this moment)
Understanding the complex behavior of immune system cells, such as B lymphocytes and T lymphocytes, in responding to cancerous growth is of central importance to cancer treatment. Natural phenomena, specifically trogocytosis and cell fusion, can lead to the development of metastases by acquiring characteristics such as genetic and epigenetic heterogeneity, chemotherapeutic resistance and …
| 1 / 1 | Ongoing research grants |
| 2 / 2 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 8 / 8 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 13 / 13 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID